Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro

References

• Radhakrishnan K, Sonali N, Moreno M, Nirmal J, Fernandez AA, Venkatraman S, Agrawal R. Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins. Drug Discov Today. 2017;22:416–23. doi:10.1016/j.drudis.2016.10.015.
   PubMed Web of Science ®Google Scholar
• National Eye Institute, Age-related macular degeneration (AMD). 2017 [ accessed 2018 May 26]. http://www.nei.nih.gov/eyedata/amd
   Google Scholar
• Foundation AMD. Dry vs wet age-related macular degeneration. 2017 [ accessed 2018 May 26].http://www.macular.org/dry-vs-wet-macular-degeneration
   Google Scholar
• Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41:3158–64.
   PubMed Web of Science ®Google Scholar
• Kim LA, D’Amore PA. A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol. 2012;181:376–79. doi:10.1016/j.ajpath.2012.06.006.
   PubMed Web of Science ®Google Scholar
• Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye. 2013;27:787–94. doi:10.1038/eye.2013.107.
   PubMed Web of Science ®Google Scholar
• El Sanharawi M, Kowalczuk L, Touchard E, Omri S, de Kozak Y, Behar-Cohen F. Protein delivery for retinal diseases: from basic considerations to clinical applications. Prog Retin Eye Res. 2010;29:443–65. doi:10.1016/j.preteyeres.2010.04.001.
   PubMed Web of Science ®Google Scholar
• Kang-Mieler JJ, Dosmar E, Liu W, Mieler WF. Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications. Expert Opin Drug Deliv. 2017;14:611–20. doi:10.1080/17425247.2016.1227785.
   PubMed Web of Science ®Google Scholar
• Adamson P, Wilde T, Dobrzynski E, Sychterz C, Polskyc R, Kurali E, Haworth R, Tang CM, Korczynska J, Cook F, et al. Single ocular injection of a sustained-release anti-VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model. J Control Release. 2016;244:1–13. doi:10.1016/j.jconrel.2016.10.026.
   PubMed Web of Science ®Google Scholar
• Xie B, Jin L, Luo Z, Yu J, Shi S, Zhang Z, Shen M, Chen H, Li X, Song Z. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease. Int J Pharm. 2015;490:375–83. doi:10.1016/j.ijpharm.2015.05.071.
   PubMed Web of Science ®Google Scholar
• Huang J, Wang W, Yu J, Yu X, Zheng Q, Peng F, He Z, Zhao W, Zhang Z, Li X, et al. Combination of dexamethasone and Avastin® by supramolecular hydrogel attenuates the inflammatory corneal neovascularization in rat alkali burn model. Colloids Surf B Biointerfaces. 2017;159:241–50. doi:10.1016/j.colsurfb.2017.07.057.
   PubMed Web of Science ®Google Scholar
• Drapala PW, Jiang B, Chiu YC, Mieler WF, Brey EM, Kang-Mieler JJ, Perez-Luna VH. The effect of glutathione as chain transfer agent in PNIPAAm-based thermo-responsive hydrogels for controlled release of proteins. Pharm Res. 2014;31:742–53. doi:10.1007/s11095-013-1195-0.
   PubMed Web of Science ®Google Scholar
• Osswald CR, Kang-Mieler JJ. Controlled and extended release of a model protein from a microsphere-hydrogel drug delivery system. Ann Biomed Eng. 2015;43:2609–17. doi:10.1007/s10439-015-1314-7.
   PubMed Web of Science ®Google Scholar
• Osswald CR, Kang-Mieler JJ. Controlled and extended in vitro release of bioactive anti-vascular endothelial growth factors from a microsphere-hydrogel drug delivery system. Curr Eye Res. 2016;41:1216–22. doi:10.3109/02713683.2015.1101140.
   PubMed Web of Science ®Google Scholar
• Turturro SB, Guthrie MJ, Appel AA, Drapala PW, Brey EM, Perez-Luna VH, Mieler WF, Kang-Mieler JJ. The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function. Biomaterials. 2011;32:3620–26. doi:10.1016/j.biomaterials.2011.01.058.
   PubMed Web of Science ®Google Scholar
• Osswald CR, Guthrie MJ, Avila A, Valio JA, Mieler WF, Kang-Mieler JJ. In vivo efficacy of an injectable microsphere-hydrogel ocular drug delivery system. Curr Eye Res. 2017;42:1293–301. doi:10.1080/02713683.2017.1302590.
   PubMed Web of Science ®Google Scholar
• Giteau A, Venier-Julienne MC, Aubert-Pouessel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles. Int J Pharm. 2008;350:14–26. doi:10.1016/j.ijpharm.2007.11.012.
   PubMed Web of Science ®Google Scholar
• Friedman M. Chemistry, biochemistry, and safety of acrylamide. Review J Agric Food Chem. 2003;51:4504–26.
   PubMed Web of Science ®Google Scholar
• Moreau MF, Chappard D, Lesourd M, Montheard JP, Basle MF. Free radicals and side products released during methylmethacrylate polymerization are cytotoxic for osteoblastic cells. J Biomed Mater Res. 1998;40:124–31.
   PubMed Web of Science ®Google Scholar
• Papadopoulos N, Martin J, Ruan Q, Rafique A, Rosconi MP, Shi E, Pyles EA, Yancopoulos GD, Stahl N, Wiegand SJ. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis. 2012;15:171–85. doi:10.1007/s10456-011-9249-6.
   PubMed Web of Science ®Google Scholar
• Vila A, Sanchez A, Tobio M, Calvo P, Alonso MJ. Design of biodegradable particles for protein delivery. J Control Release. 2002;78:15–24.
   PubMed Web of Science ®Google Scholar
• Fu X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behavior in vitro of huperzine A-PLGA microspheres. J Microencapsul. 2005;22:705–14. doi:10.1080/02652040500162196.
   PubMed Web of Science ®Google Scholar
• Jiang B, Zhang G, Brey EM. Dual delivery of chlorhexidine and platelet-derived growth factor-BB for enhanced wound healing and infection control. Acta Biomaterialia. 2013;9:4976–84. doi:10.1016/j.actbio.2012.10.005.
   PubMed Web of Science ®Google Scholar
• Allison SD. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv. 2008;5:615–28. doi:10.1517/17425247.5.6.615.
   PubMed Web of Science ®Google Scholar
• Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 2004;27:1–12.
   PubMed Web of Science ®Google Scholar
• Yoshida R, Sakai K, Okano T, Sakurai Y. Modulating the phase transition temperature and thermosensitivity in N-isopropylacrylamide copolymer gels. J Biomater Sci Polym Ed. 1994;6:585–98.
   PubMed Web of Science ®Google Scholar
• Geever LM, Devine DM, Nugent MJD, Kennedy JE, Lyons JG, Higginbotham CL. The synthesis, characterization, phase behavior and swelling of temperature sensitive physically crosslinked poly(1-vinyl-2-pyrrolidinone)/poly(N-isopropylacrylamide) hydrogels. Eur Polym J. 2006;42:69–80. doi:10.1016/j.eurpolymj.2005.09.027.
   Web of Science ®Google Scholar
• Semeraro F, Morescalchi F, Duse S, Parmeggiani F, Gambicorti E, Costagliola C. Aflibercept in wet AMD: specific role and optimal use. Drug Des Dev Ther. 2013;7:711–22. doi:10.2147/DDDT.S40215.
   PubMed Web of Science ®Google Scholar
• van Tomme SR, van Nostrum CF, Dijkstra M, de Smedt SC, Hennink WE. Effect of particle size and charge on the network properties of microsphere-based hydrogels. Eur J Pharm Biopharm. 2008;70:522–30. doi:10.1016/j.ejpb.2008.05.013.
   PubMed Web of Science ®Google Scholar
• Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials. 1989;10:557–63.
   PubMed Web of Science ®Google Scholar
• Balcao VM, Vila MM. Structural and functional stabilization of protein entities: state-of-the-art. Adv Drug Deliv Rev. 2015;93:45–41. doi:10.1016/j.addr.2014.10.005.
   Web of Science ®Google Scholar
• Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185:129–88.
   PubMed Web of Science ®Google Scholar
• Mohammadi-Samani S, Taghipour B. PLGA micro and nanoparticles in delivery of peptides and proteins: problems and approaches. Pharm Dev Technol. 2015;20:385–93. doi:10.3109/10837450.2014.882940.
   PubMed Web of Science ®Google Scholar
• Varschochian R, Jeddi-Tehrani M, Mahmoudi AR, Khoshatand MR, Atyabi F, Sabzevari A, Esfahani MR, Dinarvand R. The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments. Eur J Pharm Sci. 2013;50:341–52. doi:10.1016/j.ejps.2013.07.014.
   PubMed Web of Science ®Google Scholar
• Marquette S, Peerboom C, Yates A, Denis L, Langer I, Amighi K, Goole J. Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres. Int J Pharm. 2014;470:41–50. doi:10.1016/j.ijpharm.2014.04.063.
   PubMed Web of Science ®Google Scholar
• Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials. 1995;16:1123–30.
   PubMed Web of Science ®Google Scholar
• Kang JC, Schwendeman SP. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants. Biomaterials. 2002;23:239–45.
   PubMed Web of Science ®Google Scholar
• D’Souza S. A review of in vitro drug release test methods for nano-sized dosage forms. Adv Pharm. 2014;2014:1–12.
   Google Scholar